Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer
Clinical trial NCT03958721 · COMPLETED
Trial details
- NCT number
- NCT03958721
- Sponsor
- A Bapsi Chakravarthy, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2023-10-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.